Anticancer agent 129
Anticancer agent 129 (Compound 3a), a quinoline derivative, predicting to has anti-cancer activity[1].
Product Specifications
CAS Number
[135882-37-0]
Product Name Alternative
UR-8880
UNSPSC
12352005
Target
Drug Derivative
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/anticancer-agent-129.html
Purity
99.01
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
NC1=C2C(N(CC3=CC=CC=C3)CC2)=NC4=CC=CC=C14
Molecular Formula
C18H17N3
Molecular Weight
275.35
References & Citations
[1]Vaidya A, et al. Predicting anti-cancer activity of quinoline derivatives: CoMFA and CoMSIA approach. J Enzyme Inhib Med Chem. 2011 Dec;26 (6) :854-61.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
127133-Biotin 100 µL
GALNT13 (KIAA1918, Polypeptide N-acetylgalactosaminyltransferase 13, Polypeptide GalNAc Transferase 13, Protein-UDP Acetylgalactosaminyltransferase 13, UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 13, FLJ16031, FLJ41157, H_NH0187G20.1, MGC119459, MGC119461) (Biotin)
Ask
View Details 035540-ML490 100 µL
FBXL14, CT (FBXL14, FBL14, F-box/LRR-repeat protein 14, F-box and leucine-rich repeat protein 14) (MaxLight 490) discontinued
Ask
View Details MBS713173-02 5x 0.1 mL
Rabbit anti-human kinesin family member 17 polyclonal Antibody
Ask
View Details 